Welcome to LookChem.com Sign In|Join Free

CAS

  • or

263769-22-8

Post Buying Request

263769-22-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

263769-22-8 Usage

Description

(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is a complex organic compound with a specific stereochemistry and functional groups. It is characterized by its molecular structure, which includes a piperidine ring with a methyl ester group and a chlorophenyl moiety. (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is primarily used as a research chemical, offering potential applications in various fields due to its unique properties.

Uses

Used in Pharmaceutical Research:
(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is used as a research chemical for the development of new pharmaceuticals. Its unique structure and functional groups make it a valuable starting point for the synthesis of novel drug candidates, particularly in the areas of central nervous system disorders and other therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester serves as an intermediate or building block for the creation of more complex molecules. Its specific stereochemistry and functional groups can be exploited to produce a variety of compounds with potential applications in various industries.
Used in Material Science:
(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester may also find applications in material science, where its unique properties could be utilized to develop new materials with specific characteristics. These materials could have potential uses in various industries, such as electronics, coatings, or adhesives.
Used in Analytical Chemistry:
As a research chemical, (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester can be employed in analytical chemistry for the development of new methods and techniques. Its unique properties may be useful in the separation, detection, or quantification of other compounds, contributing to the advancement of analytical methodologies.

Check Digit Verification of cas no

The CAS Registry Mumber 263769-22-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,7,6 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 263769-22:
(8*2)+(7*6)+(6*3)+(5*7)+(4*6)+(3*9)+(2*2)+(1*2)=168
168 % 10 = 8
So 263769-22-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H18ClNO2/c1-16-8-7-12(13(9-16)14(17)18-2)10-3-5-11(15)6-4-10/h3-6,12-13H,7-9H2,1-2H3/t12-,13+/m1/s1

263769-22-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

1.2 Other means of identification

Product number -
Other names Nocaine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:263769-22-8 SDS

263769-22-8Synthetic route

(-)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate
214335-16-7

(-)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
With sodium methylate In methanol epimerization; Heating;100%
With sodium methylate In methanol for 24h; Heating;86%
With sodium methylate In methanol at 60℃; for 6h;
arecoline
63-75-2

arecoline

(4-chlorphenyl)magnesium bromide
873-77-8

(4-chlorphenyl)magnesium bromide

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Stage #1: arecoline; (4-chlorphenyl)magnesium bromide In diethyl ether at -10℃; Addition;
Stage #2: With O,O'-dibenzoyl-L-tartaric acid Racemate resolution; Further stages.;
arecoline
63-75-2

arecoline

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 56 percent / diethyl ether / 0.5 h / -10 °C
3: 86 percent / NaOMe / methanol / 24 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: tert-butyl methyl ether; diethyl ether / 3 h / -20 - -5 °C / Inert atmosphere
2: O,O'-dibenzoyl-L-tartaric acid / methanol / 0.5 h / 60 - 65 °C
3: sodium methylate / methanol / 6 h / 60 °C
View Scheme
(4-chlorphenyl)magnesium bromide
873-77-8

(4-chlorphenyl)magnesium bromide

(+-)-2-hydroxy-1-phenyl-propan-1-one

(+-)-2-hydroxy-1-phenyl-propan-1-one

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 56 percent / diethyl ether / 0.5 h / -10 °C
3: 86 percent / NaOMe / methanol / 24 h / Heating
View Scheme
(±)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate

(±)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: 86 percent / NaOMe / methanol / 24 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: O,O'-dibenzoyl-L-tartaric acid / methanol / 0.5 h / 60 - 65 °C
2: sodium methylate / methanol / 6 h / 60 °C
View Scheme
methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: lithium diisopropyl amide / tetrahydrofuran / 2 h / -70 °C / Inert atmosphere
2: O,O'-dibenzoyl-L-tartaric acid / methanol / 0.5 h / 60 - 65 °C
3: sodium methylate / methanol / 6 h / 60 °C
View Scheme
(4-chlorphenyl)magnesium bromide
873-77-8

(4-chlorphenyl)magnesium bromide

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tert-butyl methyl ether; diethyl ether / 3 h / -20 - -5 °C / Inert atmosphere
2: O,O'-dibenzoyl-L-tartaric acid / methanol / 0.5 h / 60 - 65 °C
3: sodium methylate / methanol / 6 h / 60 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-4β-(4-Chlorophenyl)-3α-(hydroxymethyl)-1-methylpiperidine
263769-24-0

(+)-4β-(4-Chlorophenyl)-3α-(hydroxymethyl)-1-methylpiperidine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 20℃;92%
With lithium aluminium tetrahydride In tetrahydrofuran92%
Stage #1: (+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃;
Stage #2: With water; ammonium chloride In tetrahydrofuran
92%
With lithium aluminium tetrahydride In tetrahydrofuran for 1h; Ambient temperature;84%
With lithium aluminium tetrahydride In tetrahydrofuran
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(3R,4S)-4-(4-Chloro-phenyl)-1-methyl-3-(3-methyl-[1,2,4]oxadiazol-5-yl)-piperidine

(3R,4S)-4-(4-Chloro-phenyl)-1-methyl-3-(3-methyl-[1,2,4]oxadiazol-5-yl)-piperidine

Conditions
ConditionsYield
With molecular sieve; sodium hydride In tetrahydrofuran Heating;74%
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(3R,4S)-4-(4-chlorophenyl)piperidine-3-carboxylic acid methyl ester

(3R,4S)-4-(4-chlorophenyl)piperidine-3-carboxylic acid methyl ester

Conditions
ConditionsYield
Stage #1: (+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate With carbonochloridic acid 1-chloro-ethyl ester; N,N,N',N'-tetramethyl-1,8-diaminonaphthalene In dichloromethane for 1.5h; Heating;
Stage #2: In methanol for 1h; Heating; Further stages.;
67%
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-4β-(4-Chlorophenyl)-1-methylpiperidine-3α-carboxylic Acid
263769-44-4

(+)-4β-(4-Chlorophenyl)-1-methylpiperidine-3α-carboxylic Acid

Conditions
ConditionsYield
With hydrogenchloride Hydrolysis; Heating;
With hydrogenchloride Heating;
With hydrogenchloride Hydrolysis; Heating;
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

2-[(3R,4S)-4-(4-Chloro-phenyl)-piperidin-3-ylmethylsulfanyl]-ethanol
896710-05-7

2-[(3R,4S)-4-(4-Chloro-phenyl)-piperidin-3-ylmethylsulfanyl]-ethanol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
4: 80 percent / 1-chloroethyl chloroformate; proton sponge / CH2Cl2
5: 56 percent / LiAlH4 / tetrahydrofuran
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

2-[(3R,4S)-4-(4-Chloro-phenyl)-piperidin-3-ylmethylsulfanyl]-1-piperidin-1-yl-ethanone
896710-06-8

2-[(3R,4S)-4-(4-Chloro-phenyl)-piperidin-3-ylmethylsulfanyl]-1-piperidin-1-yl-ethanone

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
4: 80 percent / 1-chloroethyl chloroformate; proton sponge / CH2Cl2
5: methanol
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-(3R,4S)-4-(4-chlorophenyl)-3-(iodomethyl)-1-methylpiperidine
807342-01-4

(+)-(3R,4S)-4-(4-chlorophenyl)-3-(iodomethyl)-1-methylpiperidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
View Scheme
Multi-step reaction with 2 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]acetic acid methyl ester
807342-02-5

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]acetic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
View Scheme
Multi-step reaction with 3 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]ethanol
807342-04-7

(+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]ethanol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
4: 56 percent / LiAlH4 / tetrahydrofuran
View Scheme
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetic acid methyl ester
807342-26-3

(+)-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
4: 80 percent / 1-chloroethyl chloroformate; proton sponge / CH2Cl2
View Scheme
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 80 percent / 1,8-bis(dimethylamino)naphthalene; α-chloroethyl chloroformate / CH2Cl2 / 2.5 h / Heating
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: carbonochloridic acid 1-chloro-ethyl ester; N,N,N',N'-tetramethyl-1,8-diaminonaphthalene / dichloromethane / 2.5 h / Heating / reflux
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-1-(piperidin-1-yl)ethanone
807342-17-2

(+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-1-(piperidin-1-yl)ethanone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran
2: 86 percent / Ph3P; I2; imidazole
3: 88 percent / Cs2CO3
4: methanol
View Scheme
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 92 percent / methanol / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: methanol / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-(3R,4S)-4-(4-chlorophenyl)-3-[(2-methoxyethylsulfanyl)methyl]-1-methylpiperidine
807342-06-9

(+)-(3R,4S)-4-(4-chlorophenyl)-3-[(2-methoxyethylsulfanyl)methyl]-1-methylpiperidine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2.1: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3.1: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4.1: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
5.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
5.2: 65 percent / tetra-n-butylammonium iodide / tetrahydrofuran / 20 °C
View Scheme
Multi-step reaction with 5 steps
1.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2.1: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3.1: caesium carbonate / acetonitrile / 20 °C
4.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
5.1: sodium hydride / tetrahydrofuran / 0 °C
5.2: 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethanol

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethanol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
5: 69 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
5: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N-methylacetamide
807342-14-9

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N-methylacetamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 72 percent / methanol / 24 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: methanol / 24 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-(3R,4S)-4-(4-chlorophenyl)-3-[(2-methoxyethylsulfinyl)methyl]-1-methylpiperidine

(+)-(3R,4S)-4-(4-chlorophenyl)-3-[(2-methoxyethylsulfinyl)methyl]-1-methylpiperidine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2.1: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3.1: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4.1: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
5.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
5.2: 65 percent / tetra-n-butylammonium iodide / tetrahydrofuran / 20 °C
6.1: 61 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 6 steps
1.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2.1: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3.1: caesium carbonate / acetonitrile / 20 °C
4.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
5.1: sodium hydride / tetrahydrofuran / 0 °C
5.2: 20 °C
6.1: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide
807342-27-4

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 90 percent / NH3(gas) / 2-methyl-propan-2-ol / 72 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: carbonochloridic acid 1-chloro-ethyl ester; N,N,N',N'-tetramethyl-1,8-diaminonaphthalene / dichloromethane / 2.5 h / Heating / reflux
5: ammonia / tert-butyl alcohol / 72 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]acetamide
807342-12-7

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]acetamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 95 percent / NH3 (gas) / 2-methyl-propan-2-ol / 72 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: ammonia / tert-butyl alcohol / 72 h / 20 °C / Sealed tube
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N,N-dimethylacetamide
807342-15-0

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N,N-dimethylacetamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 91 percent / methanol / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: methanol / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]acetic acid methyl ester

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]acetic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 80 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N-hydroxyacetamide
807342-13-8

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]-N-hydroxyacetamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 76 percent / hydroxylamine hydrochloride; KOH / methanol / 2 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: potassium hydroxide; hydroxylamine hydrochloride / methanol / 2 h / 5 - 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methanesulfinyl]acetamide

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methanesulfinyl]acetamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 90 percent / NH3(gas) / 2-methyl-propan-2-ol / 72 h / 20 °C
5: 73 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 6 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: carbonochloridic acid 1-chloro-ethyl ester; N,N,N',N'-tetramethyl-1,8-diaminonaphthalene / dichloromethane / 2.5 h / Heating / reflux
5: ammonia / tert-butyl alcohol / 72 h / 20 °C
6: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-acetic acid 2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]ethyl ester
807342-08-1

(+)-acetic acid 2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
5: 70 percent / 4-(dimethylamino)pyridine; pyridine / 2 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
5: pyridine / dmap / 2 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]acetamide
807342-18-3

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]acetamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 95 percent / NH3 (gas) / 2-methyl-propan-2-ol / 72 h / 20 °C
5: 69 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: ammonia / tert-butyl alcohol / 72 h / 20 °C / Sealed tube
5: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]-N-methylacetamide

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]-N-methylacetamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 72 percent / methanol / 24 h / 20 °C
5: 80 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: methanol / 24 h / 20 °C
5: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-(3R,4S)-[[4-(4-chlorophenyl)-1-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)methylsulfanyl]methyl]piperidine
807342-24-1

(+)-(3R,4S)-[[4-(4-chlorophenyl)-1-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)methylsulfanyl]methyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2.1: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3.1: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4.1: NaH / tetrahydrofuran / 2.5 h / Heating
4.2: 79 percent / 4A molecular sieves / tetrahydrofuran / 16 h / Heating
View Scheme
Multi-step reaction with 4 steps
1.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2.1: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3.1: caesium carbonate / acetonitrile / 20 °C
4.1: sodium hydride / tetrahydrofuran / 2.5 h / Heating / reflux
4.2: 16 h / Heating / reflux; Molecular sieve
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-acetic acid 2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethyl ester

(+)-acetic acid 2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 82 percent / LiAlH4 / tetrahydrofuran / 20 °C
5: 70 percent / 4-(dimethylamino)pyridine; pyridine / 2 h / 20 °C
6: 82 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 6 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
5: pyridine / dmap / 2 h / 20 °C
6: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme
(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate
263769-22-8

(+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]-N,N-dimethylacetamide

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]-N,N-dimethylacetamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 92 percent / LiAlH4 / tetrahydrofuran / 20 °C
2: 86 percent / PPh3; I2; imidazole / CH2Cl2 / 2.5 h / Heating
3: 88 percent / Cs2CO3 / acetonitrile / 20 °C
4: 91 percent / methanol / 20 °C
5: 87 percent / aq. H2O2; CH3COOH / 2.5 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2: 1H-imidazole; iodine; triphenylphosphine / dichloromethane / 2.5 h / Heating / reflux
3: caesium carbonate / acetonitrile / 20 °C
4: methanol / 20 °C
5: dihydrogen peroxide / water; acetic acid / 2.5 h / 20 °C
View Scheme

263769-22-8Relevant articles and documents

Process development toward the pilot scale synthesis of the piperidine-based cocaine analogue and potent dopamine and norepinephrine reuptake inhibitor CTDP 31,446

Mobele, Bingidimi I.,Kinahan, Taryn,Ulysse, Luckner G.,Gagnier, Steven V.,Ironside, Michael D.,Knox, Graham S.,Mohammadi, Farahnaz

, p. 914 - 920 (2012/12/23)

(+)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate hydrochloride (CTDP 31,446) is known as a dopamine reuptake inhibitor. This cocaine analogue lacking the tropane skeleton is being considered for potential treatment of cocaine addiction. Herein we report the development of a scalable process for the preparation of this compound. This study was mainly aimed at improving the process throughput, eliminating chromatographic purifications for the separation of (±)-6-cis isomer from (±)-6-trans isomer, and developing a robust crystallization for isolation of pure (±)-6-cis in a single crop with a good mass recovery. The process development work also highlights an efficient recycle of (±)-6-trans via a kinetic epimerization followed by crystallization of the resulting (±)-6-cis isomer. The resolution of (±)-6-cis and the crystallization of the final HCl salt were optimized and implemented to afford CTDP-31,446 with high purity and good mass recovery.

Analogs of cocaine

-

, (2008/06/13)

The invention provides a compound of formula (I): STR1wherein R 1, R 2, R 3, and Y have any of the meanings defined in the specification; as well a pharmaceutical composition comprising a compound of formula I; intermediates and methods useful for preparing a compound of formula I; and therapeutic methods for treating drug addiction, Parkinson''s disease or depression comprising administering a compound of formula I, to a mammal in need of such treatment.

Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: New dopamine transporter inhibitors

Tamiz, Amir P.,Smith, Miles P.,Enyedy, Istvan,Flippen-Anderson, Judith,Zhang, Mei,Johnson, Kenneth M.,Kozikowski, Alan P.

, p. 1681 - 1686 (2007/10/03)

The synthesis and biological activity of a series of 6-substituted 1-azabicyclo[3.2.1]octanes are described. 1-Azabicyclo[3.2.1]octanes represent a new class of compounds that exhibit monoamine transporter inhibitory activity highly dependent on the overall topology and the absolute stereochemistry of the molecule. (C) 2000 Elsevier Science Ltd. All rights reserved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 263769-22-8